A Monument Naming Test to Compare Memory in Alzheimer's Disease and Healthy Older Adults
Compares how people with Alzheimer's disease and healthy older adults name famous monuments.
Plain-language title generated from the registry record
Registry title: The Monument Test : A New Tool for Assessing the Ability to Name and Identify Unique Entities. (TeDIMO)
Key facts
- Where
- Grenoble, FranceSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for two groups: people with possible or probable Alzheimer's disease, and healthy older people without memory complaints. All do a task of naming and identifying famous monuments.
- Age
- 50 to 95 years
- Sex
- All sexes can join.
- Disease stage
- Alzheimer's disease group: possible or probable Alzheimer's disease with an MMSE score of 18 to 26. Control group: MMSE score of 26 or more.
- Earlier treatment
- People taking psychotropic medication (neuroleptics) cannot join.
Main reasons for not taking part
- Significant neurological or psychiatric history
- Taking psychotropic medication (neuroleptics)
- Poor command of the French language or comprehension difficulties
- Significant hearing or visual impairments
- Controls: memory complaints
Read by machine on 13 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 50 and 95 years old?
Source: NCT07367880, who can take part
Where in France
- CHU Grenoble AlpesGrenoble, FranceContact: Aurélie TRUFFOTTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- University Hospital, Grenoble
- Trial code
- NCT07367880
- Record updated
- 26 May 2026
- Original description
The goal of this study is to show a significant difference in performance between 2 groups of participants (healthy elderly people vs. people with Alzheimer Disease) in an identification and naming task involving famous monuments.Read full original descriptionShow less
The Monument Test : A New Tool for Assessing the Ability to Name and Identify Unique Entities. (TeDIMO)
The goal of this study is to show a significant difference in performance between 2 groups of participants (healthy elderly people vs. people with Alzheimer Disease) in an identification and naming task involving famous monuments.
Inclusion: Alzheimer's disease:; Age ≥ 50 years and older; Possible or probable diagnosis of Alzheimer's disease according to the revised criteria of Mac Khann et al., 2011; Score 18≤ MMSE ≤26; Controls:; Age ≥ 50 years and older; MMSE score ≥ 26 For all subjects; No objection from the participant.
Exclusion: Alzheimer's disease:; Persons referred to in Articles L1121-5 to L1121-8 of the CSP; Controls:; Memory complaints; Persons referred to in Articles L1121-5 to L1121-8 of the CSP For all subjects; Significant neurological or psychiatric history; Taking psychotropic medication (neuroleptics); Poor command of the French language, comprehension difficulties; Significant hearing or visual impairments (diplopia, nystagmus, scotoma, etc.); Insufficient exposure to the media and/or socio-cultural knowledge (questionnaire) ; Deficit in face recognition (Benton Face Recognition Test).